Stay updated on Dapagliflozin-Induced Liver Injury Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin-Induced Liver Injury Clinical Trial page.

Latest updates to the Dapagliflozin-Induced Liver Injury Clinical Trial page
- Check4 days agoChange DetectedThe page revision was bumped from v3.5.3 to v3.5.4. This indicates an updated version of the page, likely for backend or layout adjustments rather than changes to study content.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page’s footer revision/version display has been updated from v3.5.2 to v3.5.3, indicating a platform software update rather than a change to the trial study details.SummaryDifference0.1%

- Check33 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check62 days agoChange DetectedSoftware version bump: v3.4.3 → v3.5.0.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 in the page footer. No substantive content changes to the study details.SummaryDifference0.1%

- Check98 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2 with no visible changes to core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin-Induced Liver Injury Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin-Induced Liver Injury Clinical Trial page.